Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same here. Nice predictable moves great for trading. Made for a fun Friday.
* * $TEAR Video Chart Analysis 7/21/17 * *
Link to Video- watch analysis by clicking HERE
Seeing tear drops now; traders exiting for weekend!
Yes. DdSayin all. Our other one will be next. CBLI
Agreed I think we see 10 next week
I got in @ 3.14 Wished I would of bought at 1.90 when I 1st Noticed it this morning.. Live&Learn..
the Buy Volume is Pumping!!!!
Geez. where's this puppy headed?
lol exactly!!!
AEZS all over again!! LoL
$TEAR
will that drive the price upward? #fairlyNewButlearningquickly.
strong buy here!
Hold on tight ladies and gents.
Very bullish here!
Hopefully you covered.
Market makers let it collapse to collect shares.
It's why you never hold these crappy companies hoping for events.
Just wait for the event and then wait for the market makers to bring it down when they want shares.
It's predictable.
Reuters is projecting $4. over next six months.
Submission to the U.S. Food and Drug Administration, which is expected in the second half of 2017.
TEAR is a great $$$$$ opportunity.
Analysts from Thomson Reuters are "projecting that the stock will reach $4.00 on a short term basis"
TODAY?
https://rivesjournal.com/analyst-price-targets-stock-snapshots-on-tearlab-corporation-nasdaqtear-and-salisbury-bancorp-inc-nasdaqsal/228077/
TEAR that's why you do DD. posted full DD recently. I warned shorts: don't mess w/solid companies w/strong cash on hand, catalysts...
Top ? Lets see
Great buy!! I still have a few left from Last run... Crazy move
TEAR great news $$$$$$
You got that right.. I sold half on recent small spike but bought that half right back and 1.65 last week without hesitation. .. thanks Ash.. a little patience and time needed with your picks and easy $$$..
as I mentioned w/other one, you can never time it perfectly (for those who waiting for a lil cheap share and missed 50% spike)
TEAR 2.6 +50%, that's why we do DD.... exactly as our other solid undervalued stocks, been buying/added past weeks. tic toc.
Can someone tell me, what that means exactly? Some thoughts? Good or bad news?Thanks
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 23, 2017
Item 1.02 Termination of Material Definitive Agreement
On June 23, 2017, TearLab Corporation (the “Company,” “we,” or “us”) entered into a mutual termination of the Amended and Restated Cooperative Marketing Agreement with PRN Physician Recommended Nutriceuticals LLC (“PRN”) pursuant to which the Company and PRN were jointly promoting PRN’s proprietary omega-3 formulations, including Dry Eye Omega Benefits®. The termination is effective immediately, and all amounts due to the Company will be paid by June 30, 2017.
Nice pop today. I was able to sell at 1.92 all my shares that bought at 1.56.. I averaged down right on time.. still holding the other half of my position but now with decent average. Will definitely add again if it drifts lower on low volume day.
TEAR
It is very good news.. hopefully there are some shorts that were hoping for delisting.. October is a long way imo
TEAR
TearLab Receives Nasdaq Listing Extension
Good news.
Yes.. I got all my fills yesterday @1.56 to average down..
Somw Buying kicking in again.. still small volume though.
got small fills at 1.56 today and last week..
TEAR
Hi there! I am new here..is this board still alive?
What is going on?
It's all so negative that it's constantly toward the south? Thanks!
Under 10m cap (5.7m O/S) vs $13M cash and 28M revenues. What a gift. Once Edison will update EV everyone will be chasing imo. So far only real EV backup with numbers. others just throw pt's
TEAR july 2016, C.T order filed, 3 months later co.entered into Material
Definitive Agreement ( PRN). Mar 27, 2017 another C.T order... more on the works beside several Catalysts ahead.
Interesting coverage forecast sales of $145m on only a modest market penetration. Edison 14 May 2015 : "If it can achieve even modest market penetration it may reach potential yearly card sales of $145m. This assumes 10% provider penetration, 25 patients per day, 25% of patients tested and 175 clinic days per year".
Edison also said that "The current EV of $73.4m", "May not reflect market potential". current cap is only $13m (about 5m O/S) a/o May 15, 2017, extremely undervalued relating EV mentioned.
This coverage was written exactly 2 years ago before TEAR Achieved those Milestones (Achieved more than a modest market penetration as Edison forecasted):
1. Approval in the Republic of Korea by the Ministry of Health and Welfare
2. Commercial launch in the Republic of India
3. A/o May 12, 2017- approval in the Federative Republic of Brazil (the largest market in Latin America with a population of over 200 million).
CEO of TearLab Corporation said, "We are pleased to complete these major milestones for TearLab’s international business as we continue to increase our global footprint in key strategic markets. Due to their size and growing dry eye populations, these three markets represent significant opportunity for us to expand our business and continue toward our goal of making osmolarity testing a global standard of care in diagnosing dry eye disease.”
Although company still facing net loss investors always looking forward. company has an impressive grow rate:
Revenues $:
2012 3,960 first commercial launch of the TearLab Osmolarity System
2013 14,645
2014 19,718
2015 25,156
2016 28,014 expenses cut by 30% too.
More estimations made by Tearlab in 2016 confirmed Edison Valuation. June 2016 Presentation:
1. Current Run Rate - $27 million
2. Potential current customer footprint - $98 million
3. Market opportunity with current U.S. infrastructure $194 million
Strong IP Portfolio:
U.S. 11 Issued Patents
ROW 25 Issued Patents
Pending 18 Patents
https://www.tearlab.com/investors/TEAR_Investor_Presentation_LD_Micro_Final_20160609_Rev.pdf
I do expect revenues boost due solid approvals, cash/share $2.6 a/o today.
"We anticipate that our cash and cash equivalents...will be sufficient to sustain our operations into the first quarter of 2018"
Reduced both operating expenses & loss by 60% & 75% past 2 earnings.
beats on Revenues.
Updates May 15,2017 CC: https://seekingalpha.com/article/4073481-tearlabs-tear-ceo-seph-jensen-q1-2017-results-earnings-call-transcript
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
438
|
Created
|
12/07/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |